1. From the Department of Nephrology and Hypertension, University Hospital of Erlangen, Erlangen, Germany (R.E.S., S.T.S.); Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany (T.R., J.S., U.Z.); Medical Klinik B, Hospital of the City of Ludwigshafen, Ludwigshafen, Germany (U.Z.); Department of Molecular and Clinical Cardiology, Charité University Hospital Berlin, Berlin, Germany (R.D.); Clinical and Regulatory Affairs, Novartis Pharma GmbH, Nuremberg, Germany (I.H.); and Division of...